𝔖 Bobbio Scriptorium

✦ LIBER ✦

ER and PgR in breast cancer, 1993, more than a question of positivity versus negativity

✍ Scribed by Thorpe, S.M.; Christensen, I.J.; Rose, C.

Book ID: 122393960
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 154 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)90760-D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of 95-gene classifier as a p

Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients

✍ Yasuto Naoi; Kazuki Kishi; Tomonori Tanei; Ryo Tsunashima; Naoomi Tominaga; Yosu 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 502 KB

Five versus more than five years of tamo

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors: Fisher B, Dignam J, Bryant J, DeCillis A, Wickeham L, Wolmark N, Constantino J, Redmond C, Fisher ER, Bowman DM, Deschênes L, Dimitrov NV, Margolese RG, Robidoux R, Shibata H, Terz A, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickney HL J Natl Cancer Inst 1996:88:1529-42

📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 115 KB

Anastrozole is safer and may be more eff

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10

✍ Hetty Carraway; Antonio C. Wolff 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB